Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.48%244.92B | 9.40%1.05T | 20.43%267.61B | 1.63%957.94B | 13.45%242.58B | 5.34%259.03B | -7.97%234.13B | -2.75%222.21B | 24.52%942.61B | 6.65%213.82B |
| Cost of revenue | -6.10%204.7B | 8.44%865.69B | 17.89%218.01B | -0.19%798.34B | 6.06%209.9B | 3.97%211.06B | -6.10%192.45B | -4.69%184.92B | 17.35%799.88B | 4.50%197.89B |
| Gross profit | -18.93%40.21B | 14.19%182.25B | 33.06%49.6B | 11.83%159.6B | 105.30%32.69B | 11.82%47.96B | -15.72%41.67B | 8.17%37.28B | 89.35%142.72B | 43.15%15.92B |
| Operating expense | 7.86%20.37B | 5.24%79.4B | 7.05%18.89B | 18.13%75.45B | 5.82%18.69B | 43.95%22.02B | 11.58%17.1B | 13.19%17.64B | 10.66%63.87B | 5.34%17.66B |
| Operating profit | -35.40%19.84B | 22.22%102.86B | 56.42%30.72B | 6.72%84.15B | 906.51%14B | -5.99%25.94B | -27.98%24.57B | 4.02%19.64B | 346.46%78.86B | 69.22%-1.74B |
| Net non-operating interest income (expenses) | -78.56%-1.09B | 60.74%-2.28B | 63.39%-611M | 19.20%-5.81B | 26.31%-1.25B | -4.13%-1.36B | 20.15%-1.53B | 26.54%-1.67B | 25.36%-7.19B | 27.87%-1.7B |
| Non-operating interest income | 5.71%1.15B | 34.74%5.06B | 35.92%1.09B | 33.83%3.75B | 21.92%901M | -7.84%1.14B | 51.41%913M | 255.11%799M | 318.03%2.81B | 370.70%739M |
| Non-operating interest expense | 31.94%2.24B | -23.26%7.34B | -31.24%1.7B | -4.32%9.56B | -11.67%2.15B | -1.69%2.5B | -3.02%2.44B | -1.16%2.47B | -3.00%10B | -2.91%2.43B |
| Net investment income | -160.82%-4.6B | -54.85%3.86B | 22.78%7.57B | 218.61%8.55B | 871.20%6.07B | 77.49%-6B | -34.44%2.31B | -59.68%6.16B | -155.57%-7.21B | -93.78%625M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 0 | -3.47B | 0 | |||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 94.96%-91M | -1.81B | -249M | -1.38B | -179M | 0 | 0 | |||
| Income from associates and other participating interests | -80.58%7.24B | 311.39%202.05B | 52.72%37.29B | -92.17%49.11B | -68.75%17.01B | -100.77%-566M | -96.87%8.25B | -89.63%24.42B | -2.16%627.15B | -75.49%54.44B |
| Special income (charges) | 302.72%9.03B | 44,451.85%11.98B | 12.04%2.24B | -101.02%-27M | -296.24%-2.22B | -465.28%-407M | -59.23%594M | 9.52%2B | 66.65%2.65B | 21.49%-559M |
| Less:Other special charges | -302.72%-9.03B | -44,451.85%-11.98B | -12.04%-2.24B | 101.01%27M | 309.43%2.22B | 465.28%407M | 59.23%-594M | -9.52%-2B | 86.48%-2.67B | 111.84%541M |
| Less:Write off | ---- | ---- | ---- | 1,333.33%258M | ---- | ---- | ---- | ---- | -99.90%18M | ---- |
| Other non-operating income (expenses) | 360.18%294M | 744.21%1.6B | -119.76%-113M | 113.75%190M | 172.71%1.79B | -565.68%-2.04B | -125.38%-132M | 393.10%572M | 44.36%-1.38B | -244.33%-2.46B |
| Income before tax | -60.16%30.71B | 144.46%319.97B | 50.81%77.09B | -81.11%130.89B | -34.83%31.68B | -80.70%14.2B | -88.76%33.89B | -81.00%51.12B | 5.13%692.88B | -78.22%48.62B |
| Income tax | -97.03%125M | -53.76%12.38B | -65.31%4.21B | 537.58%26.77B | 136.65%3.23B | 238.16%315M | 499.41%11.1B | 1,041.71%12.13B | -149.10%-6.12B | -400.85%-8.8B |
| Net income | -58.03%30.59B | 195.41%307.6B | 86.91%72.88B | -85.10%104.12B | -50.44%28.46B | -81.19%13.88B | -92.40%22.79B | -85.45%38.99B | 8.10%698.99B | -73.93%57.42B |
| Net income continuous operations | -58.03%30.59B | 195.41%307.6B | 86.92%72.88B | -85.10%104.12B | -50.44%28.46B | -81.19%13.88B | -92.40%22.79B | -85.45%38.99B | 8.10%698.99B | -73.93%57.42B |
| Noncontrolling interests | 89.35%640M | 3.61%2.21B | -18.94%338M | -47.82%2.13B | -36.50%468M | -31.06%686M | -41.17%563M | -70.24%417M | -2.83%4.09B | -36.14%737M |
| Net income attributable to the company | -58.72%29.95B | 199.43%305.38B | 88.06%72.54B | -85.32%101.99B | -50.62%27.99B | -81.87%13.2B | -92.56%22.23B | -85.53%38.57B | 8.17%694.9B | -74.13%56.68B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -58.72%29.95B | 199.43%305.38B | 88.06%72.54B | -85.32%101.99B | -50.62%27.99B | -81.87%13.2B | -92.56%22.23B | -85.53%38.57B | 8.17%694.9B | -74.13%56.68B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -55.89%47.4 | 225.47%460.11 | 106.63%107.4488 | -83.50%141.37 | -48.43%39.4067 | -80.74%19.1033 | -91.26%30.86 | -83.59%52 | 11.99%857.01 | -70.72%76.4104 |
| Diluted earnings per share | -55.89%47.4 | 225.47%460.11 | 106.63%107.4488 | -83.50%141.37 | -48.43%39.4067 | -80.39%18.6671 | -91.25%30.86 | -83.59%52 | 11.99%857.01 | -70.72%76.4104 |
| Dividend per share | 0 | 20.00%100 | 0 | -37.50%83.3333 | -50.00%50 | 0 | 0.00%33.3333 | 0 | 100.00%133.3333 | 50.00%100 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |